Progesterone receptor polymorphisms and risk of breast cancer: Results from two Australian breast cancer studies

Breast Cancer Research and Treatment

Volumn 109, Issue 1, 2008, Pages 91-99

  Johnatty, Sharon E ^a   Spurdle, Amanda B ^a   Beesley, Jonathan ^a   Chen, Xiaoqing ^a   Hopper, John L ^b   Duffy, David L ^a   Chenevix Trench, Georgia ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Breast cancer; Haplotypes; Polymorphisms; Progesterone receptor; V660L

Indexed keywords

LEUCINE; PROGESTERONE RECEPTOR; VALINE;

ADULT; ALLELE; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER FAMILY; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; DOSE RESPONSE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; ALLELES; AUSTRALIA; BREAST NEOPLASMS; FEMALE; GENOTYPE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PROGESTERONE; RISK;

EID: 42149163753     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9627-3     Document Type: Article

References (36)

1. Bray F, McCarron P, Parkin DM (2004) The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6:229-239
2. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71:800-809
3. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85
4. Easton DF (1999) How many more breast cancer predisposition genes are there? Breast Cancer Res 1:14-17
5. Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831-1836
6. King RJ (1991) A discussion of the roles of oestrogen and progestin in human mammary carcinogenesis. J Steroid Biochem Mol Biol 39:811-818
7. Graham JD, Clarke CL (1997) Physiological action of progesterone in target tissues. Endocr Rev 18:502-519
8. Persson I (2000) Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol 74:357-364
9. Jasienska G, Thune I (2001) Lifestyle, hormones, and risk of breast cancer. BMJ 322:586-587
10. Formby B, Wiley TS (1998) Progesterone inhibits growth and induces apoptosis in breast cancer cells: inverse effects on Bcl-2 and p53. Ann Clin Lab Sci 28:360-369
11. Misrahi M, Venencie PY, Saugier-Veber P, Sar S, Dessen P, Milgrom E (1993) Structure of the human progesterone receptor gene. Biochim Biophys Acta 1216:289-292
12. Giangrande PH, Kimbrel EA, Edwards DP, McDonnell DP (2000) The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 20:3102-3115
13. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM (2000) Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289:1751-1754
14. De Vivo I, Huggins GS, Hankinson SE, Lescault PJ, Boezen M, Colditz GA, Hunter DJ (2002) A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci USA 99:12263-12268
15. De Vivo I, Hankinson SE, Colditz GA, Hunter DJ (2003) A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Res 63:5236-5238
16. Feigelson HS, Rodriguez C, Jacobs EJ, Diver WR, Thun MJ, Calle EE (2004) No association between the progesterone receptor gene +331G/A polymorphism and breast cancer. Cancer Epidemiol Biomarkers Prev 13:1084-1085
17. Romano A, Lindsey PJ, Fischer DC, Delvoux B, Paulussen AD, Janssen RG, Kieback DG (2006) Two functionally relevant polymorphisms in the human progesterone receptor gene (+331G/A and progins) and the predisposition for breast and/or ovarian cancer. Gynecol Oncol 101:287-295
18. Fernandez LP, Milne RL, Barroso E, Cuadros M, Arias JI, Ruibal A, Benitez J, Ribas G (2006) Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study. Int J Cancer 119:467-471
19. Agoulnik IU, Tong XW, Fischer DC, Korner K, Atkinson NE, Edwards DP, Headon DR, Weigel NL, Kieback DG (2004) A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk. J Clin Endocrinol Metab 89:6340-6347
20. Wang-Gohrke S, Chang-Claude J, Becher H, Kieback DG, Runnebaum IB (2000) Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Cancer Res 60:2348-2350
21. De Vivo I, Hankinson SE, Colditz GA, Hunter DJ (2004) The progesterone receptor Val660→Leu polymorphism and breast cancer risk. Breast Cancer Res 6:R636-R639
22. Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G (2002) The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women. Cancer Epidemiol Biomarkers Prev 11:439-443
23. Pooley KA, Healey CS, Smith PL, Pharoah PD, Thompson D, Tee L, West J, Jordan C, Easton DF, Ponder BA, Dunning AM (2006) Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach. Cancer Epidemiol Biomarkers Prev 15:675-682
24. Antoniou AC, Easton DF (2003) Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 25:190-202
25. Hopper JL, Giles GG, McCredie MRE, Boyle P (1994) Background, rationale and protocol for a case-control-family study of breast cancer. Breast 3:79-86
26. Hopper JL, Chenevix-Trench G, Jolley DJ, Dite GS, Jenkins MA, Venter DJ, McCredie MR, Giles GG (1999) Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr 26:95-100
27. Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M, Giles GG, Goldblatt J, Hopper JL, Kirk J, Leary JA, Lindeman G, Niedermayr E, Phillips KA, Picken S, Pupo GM, Saunders C, Scott CL, Spurdle AB, Suthers G, Tucker K, Chenevix-Trench G (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8:R12
28. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434
29. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
30. Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC (2005) Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. J Natl Cancer Inst 97:51-59
31. Risch HA, Bale AE, Beck PA, Zheng W (2006) PGR +331A/G and increased risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 15:1738-1741
32. Terry KL, De Vivo I, Titus-Ernstoff L, Sluss PM, Cramer DW (2005) Genetic variation in the progesterone receptor gene and ovarian cancer risk. Am J Epidemiol 161:442-451
33. Berchuck A, Schildkraut JM, Wenham RM, Calingaert B, Ali S, Henriott A, Halabi S, Rodriguez GC, Gertig D, Purdie DM, Kelemen L, Spurdle AB, Marks J, Chenevix-Trench G (2004) Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers. Cancer Epidemiol Biomarkers Prev 13:2141-2147
34. Huggins GS, Wong JY, Hankinson SE, De Vivo I (2006) GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism. Cancer Res 66:1384-1390
35. Breast Cancer Association C (2006) Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 98:1382-1396
36. Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150